9635 Granite Ridge Drive
Suite 100
San Diego, CA 92123
United States
858 459 7800
http://www.aethlonmedical.com
Sector(s):Â Healthcare
Industry:Â Medical Devices
Full Time Employees:Â 8
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Dr. Charles J. Fisher Jr. | CEO, Director & Member of Extracorporeal Therapy Advisory Board | 124k | N/A | 1947 |
Mr. James B. Frakes | CFO, Sr. VP of Fin. & Sec. | 354.75k | N/A | 1957 |
Mr. Guy F. Cipriani BS (Eng.), MBA | Sr. VP, Chief Bus. Officer & Director | 34k | N/A | 1971 |
Mr. Sunil Sawhney | Head of Clinical Studies | N/A | N/A | N/A |
Mr. Steven P. Larosa | Chief Medical Officer | N/A | N/A | N/A |
Dr. Richard H. Tullis | Consultant | N/A | N/A | 1945 |
Aethlon Medical, Inc., a medical technology company, focuses on developing products to diagnose and treat life and organ threatening diseases in the United States. The company is developing Aethlon Hemopurifier, a clinical-stage immunotherapeutic device that removes exosomes and life-threatening viruses from the human circulatory system. It is also developing TauSome, an exosomal biomarker candidate to diagnose chronic traumatic encephalopathy in living individuals. Aethlon Medical, Inc. has a collaboration with the University of Pittsburgh for studies related to head and neck cancer. The company is based in San Diego, California.
Aethlon Medical, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.